Will you have Salivary gland atrophy with Creat - from FDA reports

Summary

There is no Salivary gland atrophy reported by people who take Creat yet. This review analyzes which people have Salivary gland atrophy with Creat. It is created by eHealthMe based on reports from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on andrographis (the active ingredients of Creat) and Creat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Salivary gland atrophy are also considered in the study.

What is Creat?

Creat has active ingredients of andrographis. (latest outcomes from Creat 1 users)

What is Salivary Gland Atrophy?

Salivary gland atrophy (wasting of salivary gland) has been reported by people with fever, breast cancer metastatic, schizophrenia, high blood cholesterol, renal failure chronic (latest reports from 18 Salivary gland atrophy patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 22, 2019

No report is found.


Do you have Salivary gland atrophy while taking Creat?

You are not alone:




Related studies

Drugs that are associated with Salivary gland atrophy
Salivary gland atrophy
Could your condition cause Salivary gland atrophy
Salivary gland atrophy
Creat side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Creat
a b c d e f g h i j k l m n o p q r s t u v w x y z


What would happen?

Predict new side effects and undetected conditions when you take Creat and have Salivary gland atrophy




Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.